To evaluate the effect of miR-23a on pancreatic cancer cell EMT, we transfected miR-23a inhibitors (miR-23a inhibitor) and the inhibitor control (inhibitor NC) into Aspc-1 and Bxpc-3 cells treated with TGF-β1. The gene discussed is TGFB1; the disease is familial pancreatic carcinoma.